Policy, Equity and Priority: Ethical Issues of Stem Cell in Developing Countries

Ever-increasing advances in the field of bioethics have been encouraged by recent developments of biomedical technolo-gies. Stem cell research and therapy are among the most promising approaches in medicine of which are raised some ethical chal¬lenges. Likewise, the therapeutic potential...

Full description

Bibliographic Details
Main Authors: B Larijani, F Zahedi
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2008-06-01
Series:Iranian Journal of Public Health
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/8587.pdf&manuscript_id=8587
_version_ 1818726603065131008
author B Larijani
F Zahedi
author_facet B Larijani
F Zahedi
author_sort B Larijani
collection DOAJ
description Ever-increasing advances in the field of bioethics have been encouraged by recent developments of biomedical technolo-gies. Stem cell research and therapy are among the most promising approaches in medicine of which are raised some ethical chal¬lenges. Likewise, the therapeutic potential of stem cell-based therapies created new policy concerns for health care sys¬tems, particularly the issue of equity, priority in resource allocation and justice. There are arguments against and in favor of funding for stem cell research. Governments have also diverse policies in en¬couraging private sector sponsorship to support researches. Iran is one of the pioneers in the field of human embry¬onic stem cell research in the region. The religious de¬crees per¬mitting therapeutic purposes have paved the way for wide-ranging researches. Indeed, the researchers have an obli¬gation to observe moral values. Therefore, the national specific guideline for gamete and embryo research, com¬piled in 2005, is followed in this issue. In this paper, we will discuss the major ethical concerns relating to the issue of equity and justice, and will review the regulatory policies for stem cell research and therapy. On the whole, stem cell research is a global enterprise about which there is a need to think in the context of glob¬alisation and also from the perspective of the developing countries. Stem cell based therapies are expensive and tech¬nologically demanding, the low-resource healthcare systems need to consider a specific national policy and to weigh up costs and benefits to consider making such treatments available. We must ensure that rights, values and wel¬fare of the donor, recipient and the community are respected.
first_indexed 2024-12-17T22:00:49Z
format Article
id doaj.art-e4b7001cfc484988a4faf4d66a9396e2
institution Directory Open Access Journal
issn 2251-6085
language English
last_indexed 2024-12-17T22:00:49Z
publishDate 2008-06-01
publisher Tehran University of Medical Sciences
record_format Article
series Iranian Journal of Public Health
spelling doaj.art-e4b7001cfc484988a4faf4d66a9396e22022-12-21T21:30:59ZengTehran University of Medical SciencesIranian Journal of Public Health2251-60852008-06-01371 Sup111Policy, Equity and Priority: Ethical Issues of Stem Cell in Developing CountriesB LarijaniF ZahediEver-increasing advances in the field of bioethics have been encouraged by recent developments of biomedical technolo-gies. Stem cell research and therapy are among the most promising approaches in medicine of which are raised some ethical chal¬lenges. Likewise, the therapeutic potential of stem cell-based therapies created new policy concerns for health care sys¬tems, particularly the issue of equity, priority in resource allocation and justice. There are arguments against and in favor of funding for stem cell research. Governments have also diverse policies in en¬couraging private sector sponsorship to support researches. Iran is one of the pioneers in the field of human embry¬onic stem cell research in the region. The religious de¬crees per¬mitting therapeutic purposes have paved the way for wide-ranging researches. Indeed, the researchers have an obli¬gation to observe moral values. Therefore, the national specific guideline for gamete and embryo research, com¬piled in 2005, is followed in this issue. In this paper, we will discuss the major ethical concerns relating to the issue of equity and justice, and will review the regulatory policies for stem cell research and therapy. On the whole, stem cell research is a global enterprise about which there is a need to think in the context of glob¬alisation and also from the perspective of the developing countries. Stem cell based therapies are expensive and tech¬nologically demanding, the low-resource healthcare systems need to consider a specific national policy and to weigh up costs and benefits to consider making such treatments available. We must ensure that rights, values and wel¬fare of the donor, recipient and the community are respected.http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/8587.pdf&manuscript_id=8587PolicyEquity
spellingShingle B Larijani
F Zahedi
Policy, Equity and Priority: Ethical Issues of Stem Cell in Developing Countries
Iranian Journal of Public Health
Policy
Equity
title Policy, Equity and Priority: Ethical Issues of Stem Cell in Developing Countries
title_full Policy, Equity and Priority: Ethical Issues of Stem Cell in Developing Countries
title_fullStr Policy, Equity and Priority: Ethical Issues of Stem Cell in Developing Countries
title_full_unstemmed Policy, Equity and Priority: Ethical Issues of Stem Cell in Developing Countries
title_short Policy, Equity and Priority: Ethical Issues of Stem Cell in Developing Countries
title_sort policy equity and priority ethical issues of stem cell in developing countries
topic Policy
Equity
url http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/8587.pdf&manuscript_id=8587
work_keys_str_mv AT blarijani policyequityandpriorityethicalissuesofstemcellindevelopingcountries
AT fzahedi policyequityandpriorityethicalissuesofstemcellindevelopingcountries